Research and Development

  1. Synopsis of R&D Pipeline and Agreement Status

  2. Drug Discovery

  3. Natural Products

  4. Traditional Chinese Medicines (“TCM”)

  5. Cell systems

  6. Phytopharmaceuticals today

  7. Patent strategy and Technology

  8. Development strategy

  9. Anti-cancer products: TriptoSar and other candidates

  10. Immune Suppression Products: WilGraf and other candidates

  11. Pulmonary Fibrosis: WilVent

  12. Neuroprotective Agents: NeuroTriptin

  13. Controlling PG490 Supply

  14. Cytomegalovirus Infection: PG36

  15. Hematopoiesis product: PG2

  16. Hematopoiesis product: PG2-2000

  17. B50 as Next Lead Candidate for hematopoiesis

  18. Collaborative relationships

  19. Future Discovery

  20. Selected Publications

 

Pipeline ] Research ] Development ] New Areas ] PG490 Supply ] PG2 ] PG2-2000 ] B50 ] PG36 ] Collaborations ] Discovery ] Publications ]

Management ] [ R&D ] IP ] Contact ] Site Map ]

Home ]